MannKind Corporation

391 articles about MannKind Corporation

• MannKind Corporation Submits NDA for AFRESA for Treatment of Diabetes

  3/17/2009

• MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on February 17, 2009

  2/12/2009

• MannKind Corporation Reports Successful Completion of Device Bioequivalence Trial

  1/14/2009

• SemBioSys Genetics Inc. Receives US$2.5 Million from Option Agreement with MannKind Corporation for Plant-Produced Insulin

  1/6/2009

• MannKind Corporation Reports Top-Line Results from Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes

  12/18/2008

• MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes

  12/16/2008

• MannKind Corporation's Two Phase 3 Studies Meet Goal

  12/4/2008

• MannKind Corporation Reports Third Quarter Financial Results - Conference Call Today at 9:00 a.m. EST -

  11/5/2008

• MannKind Corporation Opens $114 Million Production Plant in Connecticut

  9/17/2008

• MannKind Corporation (JOBS) Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes Study 009 Meets Its Primary Endpoint

  9/16/2008

• MannKind Corporation (JOBS) and Pfizer Inc. (JOBS) Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy

  9/16/2008

• MannKind Corporation to Host Webcast Analyst Day September 16, 2008 Company To Review Data from First Pivotal Phase 3 Clinical Trial

  9/11/2008

• MannKind Corporation Dedicates New Insulin Production Facility Sept. 17 in Danbury, Conn.

  9/10/2008

• MannKind Corporation Reports Second Quarter Financial Results

  8/12/2008

• The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement New Partnership under LLS's Therapy Acceleration Program to Advance Development of a Novel Targeted Therapy for T-Cell Leukemia and Lymphoma

  5/6/2008

• MannKind Corporation Ends Partner Talks on Inhaled Insulin

  4/10/2008

• MannKind Corporation Response to Recent Market Events

  3/11/2008

• MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results

  3/4/2008

• MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008

  2/29/2008

• MannKind Corporation to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

  2/4/2008